Foundry Healthcare NetDebtPrice Factor ETF
ETF Foundry Research (hypothetical) · rebalanced monthly
The long-leg breakdown couldn’t be loaded. The service didn’t respond, so this is a gap in what we could fetch — not a statement about the factor.
Reloading the page usually resolves it.
Hypothetical growth of $1 — long-short backtest
Gross of the placeholder expense ratio and trading costs · not investor results
The performance chart couldn’t be loaded. The service didn’t respond, so this is a gap in what we could fetch — not a statement about the factor.
Reloading the page usually resolves it.
Holdings
Every constituent of the long leg — sort, search or filter by sector
| Ticker | Company | Sector | Market cap | Weight |
|---|---|---|---|---|
1CNC | CENTENE CORP | Healthcare | $32.81B | 19.35% |
2INCY | INCYTE CORP | Healthcare | $23.42B | 13.81% |
3MOH | MOLINA HEALTHCARE INC | Healthcare | $11.74B | 6.92% |
4BMRN | BIOMARIN PHARMACEUTICAL INC | Healthcare | $11.52B | 6.79% |
5OSCR | OSCAR HEALTH INC | Healthcare | $8.77B | 5.17% |
6IMVT | IMMUNOVANT INC | Healthcare | $8.27B | 4.87% |
7DNTH | DIANTHUS THERAPEUTICS INC | Healthcare | $5.77B | 3.40% |
8DYN | DYNE THERAPEUTICS INC | Healthcare | $3.92B | 2.31% |
9CPRX | CATALYST PHARMACEUTICALS INC | Healthcare | $3.85B | 2.27% |
10PRVA | PRIVIA HEALTH GROUP INC | Healthcare | $3.39B | 2.00% |
11IMNM | IMMUNOME INC | Healthcare | $2.53B | 1.49% |
12AMLX | AMYLYX PHARMACEUTICALS INC | Healthcare | $1.97B | 1.16% |
13OCUL | OCULAR THERAPEUTIX INC | Healthcare | $1.96B | 1.16% |
14HRMY | HARMONY BIOSCIENCES HOLDINGS INC | Healthcare | $1.96B | 1.15% |
15DMRA | DAMORA THERAPEUTICS INC | Healthcare | $1.94B | 1.14% |
16ZBIO | ZENAS BIOPHARMA INC | Healthcare | $1.86B | 1.10% |
17BCAX | BICARA THERAPEUTICS INC | Healthcare | $1.82B | 1.08% |
18TSHA | TAYSHA GENE THERAPIES INC | Healthcare | $1.71B | 1.01% |
19CMPS | COMPASS PATHWAYS PLC | Healthcare | $1.67B | 0.98% |
20INVA | INNOVIVA INC | Healthcare | $1.60B | 0.94% |
21VIR | VIR BIOTECHNOLOGY INC | Healthcare | $1.59B | 0.94% |
22MLTX | MOONLAKE IMMUNOTHERAPEUTICS | Healthcare | $1.45B | 0.85% |
23OMDA | OMADA HEALTH INC | Healthcare | $1.41B | 0.83% |
24AKTS | AKTIS ONCOLOGY INC | Healthcare | $1.33B | 0.78% |
25AZTA | AZENTA INC | Healthcare | $1.21B | 0.71% |
26SDGR | SCHRODINGER INC | Healthcare | $1.14B | 0.68% |
27WVE | WAVE LIFE SCIENCES LTD | Healthcare | $1.12B | 0.66% |
28PRCT | PROCEPT BIOROBOTICS CORP | Healthcare | $1.09B | 0.65% |
29BIOA | BIOAGE LABS INC | Healthcare | $1.01B | 0.60% |
30VOR | VOR BIOPHARMA INC | Healthcare | $980M | 0.58% |
31ANRO | ALTO NEUROSCIENCE INC | Healthcare | $967M | 0.57% |
32ANNX | ANNEXON INC | Healthcare | $950M | 0.56% |
33LBRX | LB PHARMACEUTICALS INC | Healthcare | $901M | 0.53% |
34TBPH | THERAVANCE BIOPHARMA INC | Healthcare | $873M | 0.51% |
35REPL | REPLIMUNE GROUP INC | Healthcare | $859M | 0.51% |
36SLDB | SOLID BIOSCIENCES INC | Healthcare | $859M | 0.51% |
37AVR | ANTERIS TECHNOLOGIES GLOBAL CORP | Healthcare | $823M | 0.49% |
38ZVRA | ZEVRA THERAPEUTICS INC | Healthcare | $755M | 0.45% |
39CADL | CANDEL THERAPEUTICS INC | Healthcare | $746M | 0.44% |
40AURA | AURA BIOSCIENCES INC | Healthcare | $723M | 0.43% |
41SGP | SPYGLASS PHARMA INC | Healthcare | $661M | 0.39% |
42TECX | TECTONIC THERAPEUTIC INC | Healthcare | $615M | 0.36% |
43NGNE | NEUROGENE INC | Healthcare | $590M | 0.35% |
44STTK | SHATTUCK LABS INC | Healthcare | $577M | 0.34% |
45ANGO | ANGIODYNAMICS INC | Healthcare | $558M | 0.33% |
46IMMX | IMMIX BIOPHARMA INC | Healthcare | $558M | 0.33% |
47VSTM | VERASTEM INC | Healthcare | $530M | 0.31% |
48ZURA | ZURA BIO LTD | Healthcare | $518M | 0.31% |
49ARVN | ARVINAS INC | Healthcare | $517M | 0.30% |
50PRTA | PROTHENA CORP PUBLIC LTD CO | Healthcare | $453M | 0.27% |
51BNTC | BENITEC BIOPHARMA INC | Healthcare | $439M | 0.26% |
52CCRN | CROSS COUNTRY HEALTHCARE INC | Healthcare | $428M | 0.25% |
53TENX | TENAX THERAPEUTICS INC | Healthcare | $420M | 0.25% |
54CBIO | CRESCENT BIOPHARMA INC | Healthcare | $407M | 0.24% |
55ABEO | ABEONA THERAPEUTICS INC | Healthcare | $399M | 0.24% |
56STRO | SUTRO BIOPHARMA INC | Healthcare | $391M | 0.23% |
57UPB | UPSTREAM BIO INC | Healthcare | $382M | 0.22% |
58SLP | SIMULATIONS PLUS INC | Healthcare | $369M | 0.22% |
59FENC | FENNEC PHARMACEUTICALS INC | Healthcare | $365M | 0.22% |
60VNDA | VANDA PHARMACEUTICALS INC | Healthcare | $327M | 0.19% |
61CARL | CARLSMED INC | Healthcare | $317M | 0.19% |
62LYEL | LYELL IMMUNOPHARMA INC | Healthcare | $311M | 0.18% |
63FHTX | FOGHORN THERAPEUTICS INC | Healthcare | $305M | 0.18% |
64MASS | 908 DEVICES INC | Healthcare | $278M | 0.16% |
65SGHT | SIGHT SCIENCES INC | Healthcare | $274M | 0.16% |
66TRDA | ENTRADA THERAPEUTICS INC | Healthcare | $268M | 0.16% |
67QTTB | Q32 BIO INC | Healthcare | $255M | 0.15% |
68SRZN | SURROZEN INC | Healthcare | $255M | 0.15% |
69RNAC | CARTESIAN THERAPEUTICS INC | Healthcare | $243M | 0.14% |
70UTMD | UTAH MEDICAL PRODUCTS INC | Healthcare | $222M | 0.13% |
71KROS | KEROS THERAPEUTICS INC | Healthcare | $211M | 0.12% |
72RNA | ATRIUM THERAPEUTICS INC | Healthcare | $208M | 0.12% |
73IMUX | IMMUNIC INC | Healthcare | $207M | 0.12% |
74DTIL | PRECISION BIOSCIENCES INC | Healthcare | $203M | 0.12% |
75AMWL | AMERICAN WELL CORP | Healthcare | $199M | 0.12% |
76TNXP | TONIX PHARMACEUTICALS HOLDING CORP | Healthcare | $198M | 0.12% |
77ACOG | ALPHA COGNITION INC | Healthcare | $185M | 0.11% |
78INGN | INOGEN INC | Healthcare | $178M | 0.10% |
79KRRO | KORRO BIO INC | Healthcare | $177M | 0.10% |
80ARCT | ARCTURUS THERAPEUTICS HOLDINGS INC | Healthcare | $172M | 0.10% |
81CRBP | CORBUS PHARMACEUTICALS HOLDINGS INC | Healthcare | $167M | 0.10% |
82LENZ | LENZ THERAPEUTICS INC | Healthcare | $162M | 0.10% |
83OWLT | OWLET INC | Healthcare | $162M | 0.10% |
84UNCY | UNICYCIVE THERAPEUTICS INC | Healthcare | $144M | 0.08% |
85PMN | PROMIS NEUROSCIENCES INC | Healthcare | $136M | 0.08% |
86VTVT | VTV THERAPEUTICS INC | Healthcare | $130M | 0.08% |
87AARD | AARDVARK THERAPEUTICS INC | Healthcare | $128M | 0.08% |
88JYNT | JOINT CORP | Healthcare | $127M | 0.07% |
89CUE | CUE BIOPHARMA INC | Healthcare | $126M | 0.07% |
90SPRB | SPRUCE BIOSCIENCES INC | Healthcare | $120M | 0.07% |
91VRCA | VERRICA PHARMACEUTICALS INC | Healthcare | $96M | 0.06% |
92RLYB | RALLYBIO CORP | Healthcare | $87M | 0.05% |
93FRMM | FORUM MARKETS INC | Healthcare | $83M | 0.05% |
94ACET | ADICET BIO INC | Healthcare | $76M | 0.04% |
95LNSR | LENSAR INC | Healthcare | $70M | 0.04% |
96LONA | LEONABIO INC | Healthcare | $68M | 0.04% |
97IMA | IMAGENEBIO INC | Healthcare | $61M | 0.04% |
98EDSA | EDESA BIOTECH INC | Healthcare | $59M | 0.03% |
99INKT | MINK THERAPEUTICS INC | Healthcare | $53M | 0.03% |
100XLO | XILIO THERAPEUTICS INC | Healthcare | $53M | 0.03% |
Full long-leg book as of July 2026 · cap-weighted · total market cap $169.57B. Hypothetical model holdings — not a registered fund’s portfolio.
Sector Breakdown
Portfolio Style
Size × value map of the long-leg book
The portfolio style map couldn’t be loaded. The service didn’t respond, so this is a gap in what we could fetch — not a statement about the factor.
Reloading the page usually resolves it.
Constraint checks
How this book measures against the concentration and liquidity rules — as implemented here
The constraint checks couldn’t be loaded. The service didn’t respond, so this is a gap in what we could fetch — not a statement about the factor.
Reloading the page usually resolves it.
Derivatives risk (Rule 18f-4)
Whether this long-only book is subject to the VaR tests at all
The 18f-4 assessment couldn’t be loaded. The service didn’t respond, so this is a gap in what we could fetch — not a statement about the factor.
Reloading the page usually resolves it.
Since publication
Did the edge survive the paper coming out?
The publication comparison couldn’t be loaded. The service didn’t respond, so this is a gap in what we could fetch — not a statement about the factor.
Reloading the page usually resolves it.
Consistency across eras
Is this record broadly durable, or one regime?
The era consistency couldn’t be loaded. The service didn’t respond, so this is a gap in what we could fetch — not a statement about the factor.
Reloading the page usually resolves it.
Returns
Long leg is what this fund holds — long-short is shown for reference
The returns table couldn’t be loaded. The service didn’t respond, so this is a gap in what we could fetch — not a statement about the factor.
Reloading the page usually resolves it.
Fund Facts
Methodology
The Foundry Healthcare NetDebtPrice Factor ETF tracks a rules-based model that ranks Healthcare common stocks each month by a NetDebtPrice signal and holds the top quintile with the lowest values. Signals are computed from point-in-time Sharadar fundamentals and total-return prices. The portfolio reconstitutes monthly and is cap-weighted within the long leg.
This is a hypothetical model portfolio for research display only — not a registered fund, not an offer, and not investment advice.
Documents (draft — hypothetical)
Auto-generated from the model’s metrics and current holdings. Every document is labeled DRAFT / hypothetical.
Objective, fees, strategy, and key risks.
Full strategy, model methodology, and risks.
Policies, construction, and governance.
One-page snapshot with top holdings.
Full current constituent list.
DRAFT — HYPOTHETICAL MODEL PORTFOLIO — NOT A REGISTERED FUND, NOT AN OFFER TO SELL SECURITIES, NOT INVESTMENT ADVICE.